Unhealthy lifestyles and aging demographics are increasing the prevalence of diabetes and heart disease. These diagnoses impair blood flow and the electrical signals which govern wound healing processes, creating chronic wounds*. Chronic wounds are devastating for the patient’s quality of life**, and constitute an overwhelming challenge for caregivers and healthcare systems. More efficacious and scalable treatments are urgently needed.
*Chen, Reid, Zhao et. al., Diabetic cornea wounds produce significantly weaker electric signals that may contribute to impaired healing, Scientific Reports volume 6, Article number: 26525 (2016)
Hiperpatch is a next-generation wound care device focusing on improving outcomes and patients’ quality of life while simultaneously also relieving caregivers and reducing the total cost of care. Hiperpatch catalyses healing by combining microcurrent stimulation, bio-feedback, and science-based algorithms to reinforce suppressed signaling systems and activate healing processes. Hiperpatch is also relevant for surgical wounds and cosmetic surgery.
A scientific in vitro study on scratch assays in a wound healing model measured the effect of the Hiperpatch algorithm on the rate and direction of cell-migration vs. normal direct current (DC) vs. a control (zero stimulation)*. The data clearly show that both DC and Hiperpatch improve the cell migration vs. the control, with Hiperpatch being superior. The study is scheduled to be published in the spring of 2021.